SepNet - Critical Care Trials Group

Quick facts

Phase 3 pipeline

• Actrapid® (Insulin) · Diabetes
  Actrapid is a rapid-acting human insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• SepNet - Critical Care Trials Group portfolio CI brief
• SepNet - Critical Care Trials Group pipeline updates RSS